X
Xinyao Paike Medical Technology
High-end pharmaceutical packaging materials and medical devices
About Xinyao Paike Medical Technology
Shanghai InnoPac Medical Technology Co., Ltd. is a science and technology enterprise founded in October 2021, specializing in high-end pharmaceutical packaging materials and medical devices for pharmaceutical companies. In a strategic move to enhance its product line and market reach, the company acquired Shanghai Bravo Technology Co., Ltd., which focused on outsourcing materials for the same sectors. This acquisition streamlined sales channels and secured key customer accounts, fostering sales growth.
The company operates a 2,500-square-meter, fully automatic and intelligent manufacturing plant. InnoPac's product portfolio is categorized into Injection, Transfer, Self-injection, and Customized Systems. Key products include the award-winning Intesafe™ integrated safety prefillable syringe, Luer-lock prefillable syringes, various needle protectors, and a series of disposable and reusable injection pens like the Inpacpen®. The company also develops customized solutions such as packaging for hyaluronic acid products and intraocular lens (IOL) injection systems for cataract surgery. By early 2023, InnoPac had successfully passed ISO9001/ISO13485 quality management system certification.
As of early 2026, the company's energy-stored disposable cartridge injection pen (Inpacpen ESP®) entered mass production, with an annual capacity in the tens of millions, positioning InnoPac among a select few global companies with this capability. The company's R&D efforts are substantial, with a team of doctors, masters, and undergraduates who have applied for 49 patents, including 18 for inventions. InnoPac serves both domestic and international clients, including a partnership with Egyptian pharmaceutical company EVA Pharma.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 44.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Pharmaceutical, Non-Invasive medical devices and treatments, Surgical Equipment, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2026 | $14M | $55M | Huatai Zijin Investment · Dongbao Pharmaceutical · GF Xinde Investment | ↗ |
Growth signals
Latest recorded traffic for Xinyao Paike Medical Technology is 260 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Xinyao Paike Medical Technology in the Huangpu ecosystem
The Xinyao Paike Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- GIGF Xinde Investment
Huatai Zijin Investment
Dongbao Pharmaceutical
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Xinyao Paike Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xinyao Paike Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







